Brief: Hungary's Richter Says 2026 Guidance Fully Reiterated High-Single-Digit Growth In Revenues And Clean EBIT (At Constant Exchange Rates)
12/05/2026 05:12
May 12 (Reuters) - Richter Gedeon Vegyeszeti Gyar Nyrt GDRB.BU: HUNGARY'S RICHTER - 2026 GUIDANCE FULLY REITERATED; HIGH-SINGLE-DIGIT GROWTH IN REVENUES AND CLEAN EBIT (AT CONSTANT EXCHANGE RATES) RICHTER: PHARMA REVENUES HUF 217.3 BILLION IN Q1 2026 HUNGARY’S RICHTER: QTRLY EBIT (PROFIT FROM OPERATIONS) HUF 67.37 BILLION RICHTER - Q1 REVENUES HUF 220.20 BILLION Source text: https://tinyurl.com/2ym69sju Further company coverage: GDRB.BU ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Richter Gedeon Vegyeszeti Gyar Nyrt
See all newsAI in Hungary could unlock productivity gains of €15 billion, McKinsey says
Brief: Hungary's Richter and Hetero announce cooperation for development of semaglutide injection
Brief: Hungary's Richter and Acrux agree to license transdermal Estradiol spray for Australia
Brief: Hungary's Richter Says 2026 Guidance Fully Reiterated High-Single-Digit Growth In Revenues And Clean EBIT (At Constant Exchange Rates)
Brief: Hungary's Richter says European Commission granted approval for Tuyory, its biosimilar to Tocilizumab